Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study.
Stegmayr BG, Brännström M, Bucht S, Crougneau V, Dimeny E, Ekspong A, Eriksson M, Granroth B, Gröntoft KC, Hadimeri H, Holmberg B, Ingman B, Isaksson B, Johansson G, Lindberger K, Lundberg L, Mikaelsson L, Olausson E, Persson B, Stenlund H, Wikdahl AM; Nediat Study Group.
Stegmayr BG, et al. Among authors: stenlund h.
Scand J Urol Nephrol. 2005;39(6):489-97. doi: 10.1080/00365590500329304.
Scand J Urol Nephrol. 2005.
PMID: 18161210
Clinical Trial.